Search Results 1071-1080 of 18626 for Relapse
... Relapsed/Refractory Non-Hodgkin Lymphoma. Clin Lymphoma Myeloma Leuk ... Incidence of Central Nervous System Relapse in Primary Mediastinal Large B ...
... relapse prevention. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
... relapse) and not all survive. Previous research has identified features of FHWT that are associated with higher or lower risks of relapse. The term "risk ...
The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.
... relapse and reduction in corticosteroid requirement. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...
... relapsed NSCLC. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn ...
Patients at high risk of relapse are eligible for InPACT-pelvis, where they ... Also, to improve disease control by decreasing the number of spinal relapses ...
Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma featured. Cancer. Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.